Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)

Research Site, Bethlehem

Research Site, Hampton

Research Site, Durham

Research Site, Kinston

Research Site, New Bern

Research Site, Orangeburg

Research Site, Winter Park

Research Site, Coral Gables

Research Site, Tampa

Research Site, Chattanooga

Research Site, Knoxville

Research Site, Knoxville

Research Site, Tupelo

Research Site, Brookhaven

Research Site, Roseville

Research Site, Pontiac

Research Site, Minneapolis

Research Site, St Louis

Research Site, Kansas City

Research Site, Houston

Research Site, Houston

Research Site, San Antonio

Research Site, San Antonio

Research Site, San Antonio

Research Site, McAllen

Research Site, Austin

Research Site, Austin

Research Site, El Paso

Research Site, Denver

Research Site, Albuquerque

Research Site, Las Vegas

Research Site, Los Angeles

Research Site, Lynwood

Research Site, Whittier

Research Site, Northridge

Research Site, Granada Hills

Research Site, San Dimas

Research Site, Chula Vista

Research Site, Middlebury

Research Site, Mariánské Lázně

Research Site, Nový Jičín

Research Site, Pilsen

Research Site, Prague

Research Site, Příbram

Research Site, Slaný

Research Site, Baja

Research Site, Debrecen

Research Site, Kaposvár

Research Site, Kecskemét

Research Site, Pécs

Research Site, Pavia

Research Site, Vicenza

Research Site, Biała Podlaska

Research Site, Brodnica

Research Site, Lodz

Research Site, Pszczyna

Research Site, Sochaczew

Research Site #2, Barcelona

Research Site, Valencia